Search

In the present study, we explored the therapeutic potential of bioreactor-grown cell cultures of the medicinal plant species Dioscorea deltoidea, Tribulus terrestris and Panax japonicus to treat carbohydrate metabolism disorders (CMDs) in laboratory rats. In the adrenaline model of hyperglycemia, aqueous suspensions of cell biomass pre-administered at a dose of 100 mg dry biomass/kg significantly reduced glucose level in animal blood 1–2.5 h (D. deltoidea and T. terrestris) or 1 h (P. japonicus) after adrenaline hydrochloride administration. In a streptozotocin-induced model of type 2 diabetes mellitus, the cell biomass of D. deltoidea and T. terrestris acted towards normalization of carbohydrate and lipid metabolism, as evidenced by a significant reduction of daily diuresis (by 39– 57%), blood-glucose level (by 46–51%), blood content in urine (by 78–80%) and total cholesterol (25– 36%) compared to animals without treatment. Bioactive secondary metabolites identified in the cell cultures and potentially responsible for their actions were deltoside, 25(S)-protodioscin and protodioscin in D. deltoidea; furostanol-type steroidal glycosides and quinic acid derivatives in T. terrestris; and ginsenosides and malonyl-ginsenosides in P. japonicus. These results evidenced for high potential of bioreactor-grown cell suspensions of these species for prevention and treatment of CMD, which requires further investigation. © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This. Funding: Bioreactor cultivation of plant cell suspensions and their biochemical analysis were financially supported by the Ministry of Science and Higher Education of Russian Federation through Megagrant project no. 075-15-2019-1882 and performed by using the equipment of the large-scale research facilities “Experimental biotechnological facility” and “All-Russian Collection of cell cultures of higher plants” of the IPPRAS (EBF IPPRAS and ARCCC HP IPPRAS). Hypoglycemic activity evaluation of the cell biomass was performed with the financial support of the Russian Science Foundation project no. 19-14-00387. The results of the hypoglycemic activity evaluation were obtained by using the equipment of the Center for Collective Use “Analytical Center of the Federal State Budgetary Educational Institution of Higher Education Saint Petersburg State Chemical Pharmaceutical University (SPCPU) of the Ministry of Health of Russia”, equipped with the financial support of the Ministry of Education and Science of Russia.